Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,118 | -6,042 | 4,187 | -16,796 | -24,959 |
| Depreciation Amortization | 1,489 | 241 | -551 | -364 | -65 |
| Income taxes - deferred | N/A | N/A | 3,479 | -3,479 | N/A |
| Accounts receivable | -1,023 | -371 | -95 | 158 | 228 |
| Other Working Capital | 2,402 | -2,444 | -151 | -2,212 | -1,064 |
| Other Operating Activity | -1,879 | -2,109 | -44 | -220 | -3,150 |
| Operating Cash Flow | $-4,129 | $-10,725 | $6,825 | $-22,913 | $-29,010 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 6 | N/A | 15 | 157 | -64 |
| Other Investing Activity | 50 | 50 | -50 | 150 | -250 |
| Investing Cash Flow | $56 | $50 | $-35 | $307 | $-314 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23,500 | 4,988 | N/A | 7,788 | 9,924 |
| Other Financing Activity | -3,032 | -1,095 | 0 | 242 | 0 |
| Financing Cash Flow | $20,468 | $3,893 | $N/A | $8,030 | $9,924 |
| Exchange Rate Effect | 38 | 108 | -58 | 357 | -51 |
| Beginning Cash Position | 7,838 | 14,512 | 7,780 | 21,999 | 41,450 |
| End Cash Position | 24,271 | 7,838 | 14,512 | 7,780 | 21,999 |
| Net Cash Flow | $16,433 | $-6,674 | $6,732 | $-14,219 | $-19,451 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,129 | -10,725 | 6,825 | -22,913 | -29,010 |
| Capital Expenditure | N/A | N/A | -9 | -4 | -66 |
| Free Cash Flow | -4,129 | -10,725 | 6,816 | -22,917 | -29,076 |